Last updated on September 2018

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa


Brief description of study

This is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability, and pharmacokinetics of intravenous murepavadin combined with of one anti-pseudononas antibiotic with that of two anti-pseudomonas antibiotics in the treatment of ventilator-associated bacterial pneumonia (VABP) in adult subjects.

Clinical Study Identifier: NCT03409679

Contact Investigators or Research Sites near you

Start Over

Polyphor Ltd

Research site
Tiberias, Israel
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.